To hear about similar clinical trials, please enter your email below
Trial Title:
PAncreatic Disease Cohort of TOuLouse
NCT ID:
NCT05824403
Condition:
Pancreatic Diseases
Conditions: Official terms:
Pancreatic Diseases
Conditions: Keywords:
Pancreatic cyst
Acute pancreatitis
chronic pancreatitis
Intra Pancreatic Mucinous Neoplasia
diagnosis
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The
aim is to develop positive or differential diagnostic tools between benign potentially
malignant or malignant pancreatic pathologies. During this study the investigators
collect data and biological samples to support research project.
Detailed description:
This collection focuses on pathology of the pancreas requiring specific investigations or
management for diagnosis or treatment. Pancreatic pathologies can be classified as
malignant, potentially malignant or benign tumors. These can be solid or cystic. There is
an inflammatory attack on the pancreas, generating acute pancreatitis in the acute
period, if the inflammatory manifestations persist, chronic pancreatitis will develop.
Some lesions may be at risk of malignancy during their evolution, it is therefore
necessary to improve the performance of monitoring and diagnostic tools in order to adapt
the management of patients.
Criteria for eligibility:
Study pop:
Patients with pancreatic disease
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Patients with inflammatory or cystic exocrine pancreatic pathology
- Patient able to read and understand the information leaflet
- Patients who have agreed to participate in the study and have signed the free and
informed consent
- Patients affiliated to a social security system (including AME)
Exclusion Criteria:
- Patient with pancreatic cancer pathology
- Patients with active cancer, whatever the origin
- Pregnant or breastfeeding patients
- Patients under legal protection, guardianship or trusteeship
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Locations:
Facility:
Name:
Rangueil hospital
Address:
City:
Toulouse
Country:
France
Status:
Recruiting
Contact:
Last name:
Barbara BOURNET, MD
Phone:
0561323235
Email:
bournet.b@chu-toulouse.fr
Investigator:
Last name:
Adrian CULETTO, MD
Email:
Sub-Investigator
Investigator:
Last name:
Karl BARANGE, MD
Email:
Sub-Investigator
Investigator:
Last name:
Louis BUSCAIL, MD
Email:
Sub-Investigator
Investigator:
Last name:
Fabrice MUSCARI, MD
Email:
Sub-Investigator
Investigator:
Last name:
Charlotte MAULAT, MD
Email:
Sub-Investigator
Investigator:
Last name:
Nicolas CARRERE, MD
Email:
Sub-Investigator
Start date:
November 28, 2023
Completion date:
December 2027
Lead sponsor:
Agency:
University Hospital, Toulouse
Agency class:
Other
Source:
University Hospital, Toulouse
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05824403
